Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Finished Goods (2019 - 2020)

Historic Finished Goods for Sunshine Biopharma (SBFM) over the last 2 years, with Q4 2020 value amounting to $23771.0.

  • Sunshine Biopharma's Finished Goods rose 4940.92% to $23771.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $23771.0, marking a year-over-year increase of 4940.92%. This contributed to the annual value of $23771.0 for FY2020, which is 4940.92% up from last year.
  • Per Sunshine Biopharma's latest filing, its Finished Goods stood at $23771.0 for Q4 2020, which was up 4940.92% from $15910.0 recorded in Q4 2019.
  • Sunshine Biopharma's 5-year Finished Goods high stood at $23771.0 for Q4 2020, and its period low was $15910.0 during Q4 2019.